Sean P. Grant's Insider Trades & SAST Disclosures
Sean P. Grant's most recent trade in Vera Therapeutics Inc - Ordinary Shares - Class A was a trade of 53,800 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sean P. Grant.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 53,800 | 53,800 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 26,900 | 93,237 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 99,828 | 80,172 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.87 per share. | 03 Apr 2024 | 99,828 | 166,165 | - | 14.9 | 1,484,442 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.05 per share. | 03 Apr 2024 | 69,831 | 96,334 | - | 40.1 | 2,796,801 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.12 per share. | 03 Apr 2024 | 11,648 | 73,698 | - | 38.1 | 444,080 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.65 per share. | 03 Apr 2024 | 10,988 | 85,346 | - | 38.7 | 424,708 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.25 per share. | 03 Apr 2024 | 7,361 | 66,337 | - | 39.3 | 288,927 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 03 Apr 2024 | 6,965 | 5,000 | - | 40.1 | 278,997 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 03 Apr 2024 | 3,112 | 14,909 | - | 38.2 | 118,950 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.19 per share. | 03 Apr 2024 | 2,944 | 11,965 | - | 39.2 | 115,384 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 03 Apr 2024 | 1,505 | 0 | - | 40.1 | 60,286 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 03 Apr 2024 | 867 | 0 | - | 40.1 | 34,731 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 03 Apr 2024 | 672 | 2,144 | - | 38.2 | 25,686 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.19 per share. | 03 Apr 2024 | 639 | 1,505 | - | 39.2 | 25,044 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.05 per share. | 03 Apr 2024 | 453 | 0 | - | 40.1 | 18,144 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 03 Apr 2024 | 387 | 1,233 | - | 38.2 | 14,793 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.19 per share. | 03 Apr 2024 | 366 | 867 | - | 39.2 | 14,342 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.20 per share. | 03 Apr 2024 | 203 | 453 | - | 39.2 | 7,957 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.23 per share. | 03 Apr 2024 | 201 | 656 | - | 38.2 | 7,684 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 03 Apr 2024 | 177 | 0 | - | 40.1 | 7,090 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.21 per share. | 03 Apr 2024 | 80 | 177 | - | 39.2 | 3,137 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.19 per share. | 03 Apr 2024 | 78 | 257 | - | 38.2 | 2,979 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 97,500 | 97,500 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc - Or... | P. Grant Sean | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 26,250 | 78,683 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 16.60 per share. | 23 Jun 2023 | 5,000 | 5,992 | - | 16.6 | 83,000 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 14,285 | 35,648 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 14,285 | 15,277 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 1,620 | 18,657 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 1,620 | 1,620 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | CHIEF FINANCIAL OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2023 | 636 | 18,021 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 7.00 per share. | 06 Feb 2023 | 14,285 | 49,933 | - | 7 | 99,995 | Class A Common Stock |
| Vera Therapeutics Inc - Or... | Sean P. Grant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 33,750 | 35,268 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc - Or... | Sean P. Grant | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 180,000 | 180,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges